Michael Heckmann

发表

Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple‐dose study

D. Kubitza, S. Schwers, F. Kanefendt, 2022, British journal of clinical pharmacology.